ArticleMedical oncology (Northwood, London, England)2024

Benefits of capecitabine in hormone receptor-positive compared to hormone receptor-negative HER2 normal metastatic breast cancer.

Kadri AltundagPubMed ↗Publisher ↗

No numbers read from the abstract.